clint lord’s Post

Focused Ultrasound for Melanoma: The first participant has been treated in a new clinical trial investigating the safety and efficacy of using focused ultrasound plus immunotherapy in patients with advanced melanoma. The study, led by Lynn Dengel, MD, a surgical oncologist at UVA Health, will enroll 11 participants with advanced melanoma to receive focused ultrasound before undergoing standard of care surgery. #FocusedUltrasound #Immunotherapy #MelanomaResearch Learn more about this Foundation-funded trial: https://lnkd.in/gmdVjyzx

I am constantly amazed by the power of collaboration and teamwork in medicine. Our multidisciplinary thoracic tumor board is a perfect example of our commitment to this. But it is also thrilling when we get to prove our colleagues wrong. Just recently, we had a patient with suspected metastatic disease who was offered surgery for diagnosis because a CT biopsy was not an option. However, the patient wanted to move quickly and try a bronchoscopic biopsy instead. The tumor board team was doubtful that a bronchoscopic approach in this small very peripheral lesion would 1) get a diagnosis 2) get enough tissue for staining nor 3) get tissue for molecular testing But we met all 3 goals in less than a week after consultation. How? Robotic Bronchoscopy (Ion) + Advanced Imaging (Cios) + Mini-cryoprobe (Erbe) + Our Dedicated Procedural Team ➡️ Better success rates. We do more of these procedure than anyone nearby, one of the highest volume centers nationally. It's moments like these that remind me of the importance of being open-minded, try new approaches, and invest in the equipment & personnel for the best team based care. #teamwork #collaboration #medicine #bronchoscopy #cancerdiagnosis Note: Patient permission obtained. Atrium Health Levine Cancer Intuitive Siemens Healthineers Wake Forest University School of Medicine Society for Advanced Bronchoscopy

Detection-2 Feasibility study now open at hospitals across the UK! The Detection-2 study is looking at using a ctDNA blood test to guide treatment for patients with high-risk stage 2B/2C/3A cutaneous melanoma who have had surgery to remove it. For more information about the study, view our Melanoma TrialFinder:https://buff.ly/4gLpwnB You can also view the Detection-2 video: https://buff.ly/3DAdzT9 Detection-2 feasibility study will be open for 1 year in at least 8 centres across the UK. Keep up to date with our Find a Trial tool to know which centres/hospitals are open in real time. Find a Trial Tool: https://buff.ly/3SC5tM9 #melanoma #melanomatrial #trialfinder #clinicaltrials

MRI detects cancerous and non-cancerous issues, particularly proficient at pinpointing certain cancers. While MRI images can suggest tumor malignancy, confirmation often requires additional tests like biopsy. Moreover, MRI aids in identifying cancer spread and guides treatment planning, such as surgery or radiation. 💻 www.carefirstimaging.com 📲 (833) 682-7818 📍 Bonita Springs, Cape Coral, Fort Myers, Ocala, Pensacola, Port Orange, Tallahassee, Panama City, Two locations in Pensacola, and one in Mobile, Alabama #carefirstimaging #mriservices #mriflorida #spinecare #uprightmri #musculoskeletalimaging #neuroligicalimaging #totalspineimaging #highresolutionjointimaging #highresolutionperipheralssngiographyimaging #generalabdominalimaging #vascularsystemimaging

📢 New Book Chapter about Salvage Robotic-Assisted Radical Prostatectomy. We are thrilled to announce our contribution to a new book chapter on Salvage Robotic-Assisted Radical Prostatectomy (sRARP)! Grateful for the invitation to share our insights on this complex procedure that pushes the frontiers of both urologic surgery and robotic technology. About sRARP: Salvage Robotic-Assisted Radical Prostatectomy is a procedure performed on patients with recurrent or residual prostate cancer following failed primary treatments such as radiation or focal therapy. While it offers hope for patients, it comes with unique challenges: Increased complexity: The prior prostate-preserving treatments often result in scarring and anatomical alterations, making dissection more challenging. Potential complications: Surgeons must navigate a delicate surgical field, increasing the chances of urinary incontinence or erectile dysfunction. Optimizing outcomes: Success depends on careful patient selection, advanced robotic techniques, and a highly skilled multidisciplinary team. We are proud to contribute to advancing surgical knowledge in this area and provide insights into best practices that can benefit both physicians and patients navigating these difficult cases. Thank you to everyone involved for this incredible opportunity! #RoboticSurgery #ProstateCancer #sRARP #HealthcareInnovation #MedicalResearch Vipul Patel, M.D., F.A.C.S.

Cape Cod Healthcare has taken an innovative leap forward in lung cancer detection. We’re pleased to announce that thoracic surgeon Dr. Jeff Spillane (left in photo) and interventional pulmonologist Dr. Michael Ayers (right) performed the first Ion Robotic Bronchoscopy procedure at Cape Cod Hospital this week! Ion offers exceptional precision, navigating deep into the lungs and allowing physicians to reach small, hard-to-access lung nodules. Paired with a 3D map of a patient's low dose CT scan, this real-time biopsy method enables earlier and more accurate diagnoses — all without invasive surgery or needle punctures. To learn more, visit www.capecodhealth.org/ion #LungCancerAwareness #EarlyDetection #Innovation #Milestones

In a recent MD Anderson Cancer Center study analyzing re-excision rates in breast-conserving surgery and associated healthcare costs, "Reoperations were associated with 24% higher costs in both the commercial and Medicare cohorts, which translated into $21,607 and $8559 incremental costs, respectively." Read the study and learn how reoperations in #breastcancer care contribute to increased financial burden on the healthcare system. https://lnkd.in/e4Cj88GT

Check out the new article by Chattanooga Times Free Press on how robotic-assisted surgery can help pancreatic cancer patients. It features Edgar Johnson, a patient of Surgical Oncologist Dr. Justin Wilkes, who underwent the second Whipple Procedure at CHI Memorial. Click this link to read the full article: https://ow.ly/esVQ50TWA7W

Diagnosed with hepatic cellular carcinoma (HCC) the size of a grapefruit, Martyn wasn’t suitable for surgery and had palliative care as the only option.  A multi-disciplinary team reviewed Martyn’s case and gave him a new chance to fight against HCC through the use of Selective internal radiation therapy (SIRT), an innovative targeted radioembolisation treatment that enabled the reduction of his liver tumor. Thanks to this life-saving innovation, Martyn was then able to have surgery and today is cancer-free, looking forward to a bright future. Learn more about his inspiring story by reading the full article: https://lnkd.in/dFj-mwAE #BSCEMEA #SIRT #HCC #LiverCancerAwarenessMonth 

A new transitional pass-through payment code for LUMISIGHT™ (pegulicianine) has been granted to Lumicell™!  This will increase patient access to our new innovative technology, LumiSystem™, that helps surgeons find breast cancer during surgery that might otherwise go undetected.  This new TPT code can be used in the treatment of Medicare beneficiaries starting October 1, 2024. Read the Press Release: https://lnkd.in/e2PJ3s6M The most common side effects with LUMISIGHT are hypersensitivity and an abnormal color in urine. LUMISIGHT may cause serious hypersensitivity reactions, including anaphylaxis. Please see the LUMISIGHT Prescribing Information (https://lnkd.in/esGzxQuD), including Boxed Warning, and Lumicell DVS Instructions for Use (https://lnkd.in/eNxsTVtF). For complete product information, visit www.LumiSystem.com. #LUMISIGHT, #LumiSystem, #Lumicell